Literature DB >> 25104210

Tissue factor, protease activated receptors and pathologic heart remodelling.

Silvio Antoniak, Erica Sparkenbaugh, Rafal Pawlinski1.   

Abstract

Tissue factor is the primary initiator of coagulation cascade and plays an essential role in haemostasis and thrombosis. In addition, tissue factor and coagulation proteases contribute to many cellular responses via activation of protease activated receptors. The heart is an organ with high levels of constitutive tissue factor expression. This review focuses on the role of tissue factor, coagulation proteases and protease activated receptors in heart haemostasis and the pathological heart remodelling associated with myocardial infarction, viral myocarditis and hypertension.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25104210      PMCID： PMC4382753          DOI： 10.1160/TH14-03-0243

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


  98 in total

1.  Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension.

Authors:  Babe Bakouboula; Olivier Morel; Antoine Faure; Fatiha Zobairi; Laurence Jesel; Annie Trinh; Michel Zupan; Matthieu Canuet; Lelia Grunebaum; Agnès Brunette; Dominique Desprez; François Chabot; Emmanuel Weitzenblum; Jean-Marie Freyssinet; Ari Chaouat; Florence Toti
Journal:  Am J Respir Crit Care Med       Date:  2007-11-15       Impact factor: 21.405

2.  Letter by Strande regarding article "Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy".

Authors:  Jennifer L Strande
Journal:  Circulation       Date:  2008-06-17       Impact factor: 29.690

Review 3.  Acute myocardial infarction.

Authors:  Harvey D White; Derek P Chew
Journal:  Lancet       Date:  2008-08-16       Impact factor: 79.321

Review 4.  Role of the renin-angiotensin system in vascular inflammation.

Authors:  Chiara Marchesi; Pierre Paradis; Ernesto L Schiffrin
Journal:  Trends Pharmacol Sci       Date:  2008-06-23       Impact factor: 14.819

5.  PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts.

Authors:  Rong Jiang; Amanda Zatta; Hajime Kin; Ningping Wang; James G Reeves; James Mykytenko; Jeremiah Deneve; Zhi-Qing Zhao; Robert A Guyton; Jakob Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-24       Impact factor: 4.733

6.  Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy.

Authors:  Rafal Pawlinski; Michael Tencati; Craig R Hampton; Tetsuro Shishido; Tara A Bullard; Liam M Casey; Patricia Andrade-Gordon; Matthias Kotzsch; Denise Spring; Thomas Luther; Jun-ichi Abe; Timothy H Pohlman; Edward D Verrier; Burns C Blaxall; Nigel Mackman
Journal:  Circulation       Date:  2007-10-29       Impact factor: 29.690

7.  Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity.

Authors:  Silvio Antoniak; Ulrike Boltzen; Alexander Riad; Angela Kallwellis-Opara; Maria Rohde; Andrea Dörner; Carsten Tschöpe; Michel Noutsias; Matthias Pauschinger; Heinz-Peter Schultheiss; Ursula Rauch
Journal:  J Mol Cell Cardiol       Date:  2008-03-29       Impact factor: 5.000

8.  Inhibition of tissue factor signaling suppresses tumor growth.

Authors:  Henri H Versteeg; Florence Schaffner; Marjolein Kerver; Helle H Petersen; Jasimuddin Ahamed; Brunhilde Felding-Habermann; Yoshikazu Takada; Barbara M Mueller; Wolfram Ruf
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

9.  Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension.

Authors:  R James White; David F Meoli; Robert F Swarthout; Dara Y Kallop; Irfan I Galaria; Jennifer L Harvey; Christine M Miller; Burns C Blaxall; Carla M Hall; Richard A Pierce; Carlyne D Cool; Mark B Taubman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-06-22       Impact factor: 5.464

10.  Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling.

Authors:  Jennifer L Strande; Anna Hsu; Jidong Su; Xiangping Fu; Garrett J Gross; John E Baker
Journal:  J Pharmacol Exp Ther       Date:  2007-11-30       Impact factor: 4.030
View more
  11 in total

1.  Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.

Authors:  Silvio Antoniak; Kohei Tatsumi; Clare M Schmedes; Steven P Grover; Rafal Pawlinski; Nigel Mackman
Journal:  J Mol Cell Cardiol       Date:  2018-08-10       Impact factor: 5.000

2.  Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.

Authors:  Silvio Antoniak; Jessica C Cardenas; Laura J Buczek; Frank C Church; Nigel Mackman; Rafal Pawlinski
Journal:  Cardiology       Date:  2016-11-24       Impact factor: 1.869

3.  Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.

Authors:  Kohei Tatsumi; Clare M Schmedes; E Reaves Houston; Emily Butler; Nigel Mackman; Silvio Antoniak
Journal:  Cell Immunol       Date:  2019-07-03       Impact factor: 4.868

Review 4.  Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants.

Authors:  Anke C Fender; Reza Wakili; Dobromir Dobrev
Journal:  Pharmacol Res       Date:  2019-05-02       Impact factor: 7.658

Review 5.  The coagulation system in host defense.

Authors:  Silvio Antoniak
Journal:  Res Pract Thromb Haemost       Date:  2018-05-24

Review 6.  The microRNA in ventricular remodeling: the miR-30 family.

Authors:  Xiaonan Zhang; Shaoyang Dong; Qiujin Jia; Ao Zhang; Yanyang Li; Yaping Zhu; Shichao Lv; Junping Zhang
Journal:  Biosci Rep       Date:  2019-08-02       Impact factor: 3.840

7.  Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice.

Authors:  Masato Narita; Kenji Hanada; Yosuke Kawamura; Hiroaki Ichikawa; Shuntaro Sakai; Yoshikazu Yokono; Maiko Senoo; Noritomo Narita; Michiko Shimada; Tomohiro Osanai; Ken Okumura; Hirofumi Tomita
Journal:  Hypertens Res       Date:  2021-07-20       Impact factor: 3.872

8.  Aucubin Protects against Myocardial Infarction-Induced Cardiac Remodeling via nNOS/NO-Regulated Oxidative Stress.

Authors:  Zheng Yang; Qing-Qing Wu; Yang Xiao; Ming Xia Duan; Chen Liu; Yuan Yuan; Yan-Yan Meng; Hai Han Liao; Qi-Zhu Tang
Journal:  Oxid Med Cell Longev       Date:  2018-06-25       Impact factor: 6.543

9.  Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats.

Authors:  Chi Liu; Chuan-Xi Yang; Xi-Ru Chen; Bo-Xun Liu; Yong Li; Xiao-Zhi Wang; Wei Sun; Peng Li; Xiang-Qing Kong
Journal:  Amino Acids       Date:  2018-05-12       Impact factor: 3.520

10.  Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload.

Authors:  Xinji Guo; Mikhail A Kolpakov; Bahman Hooshdaran; William Schappell; Tao Wang; Satoru Eguchi; Katherine J Elliott; Douglas G Tilley; A Koneti Rao; Patricia Andrade-Gordon; Matthew Bunce; Chintala Madhu; Steven R Houser; Abdelkarim Sabri
Journal:  JACC Basic Transl Sci       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.